{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:04:06Z","timestamp":1792015446201,"version":"4.4.0"},"reference-count":64,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C552\/A17720"],"award-info":[{"award-number":["C552\/A17720"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C552\/A29106"],"award-info":[{"award-number":["C552\/A29106"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The interplay between oncolytic virus infection and tumour hypoxia is particularly unexplored in vivo, although hypoxia is present in virtually all solid carcinomas. In this study, oncolytic adenovirus infection foci were found within pimonidazole-reactive, oxygen-poor areas in a colorectal xenograft tumour, where the expression of VEGF, a target gene of the hypoxia-inducible factor (HIF), was attenuated. We hypothesised that adenovirus infection interferes with the HIF-signalling axis in the hypoxic tumour niche, possibly modifying the local vascular supply. In vitro, enadenotucirev (EnAd), adenovirus 11p and adenovirus 5 decreased the protein expression of HIF-1\u03b1 only during the late phase of the viral life cycle by transcriptional down-regulation and not post-translational regulation. The decreasing HIF levels resulted in the down-regulation of angiogenic factors such as VEGF, coinciding with reduced endothelial tube formation but also increased T-cell activation in conditioned media transfer experiments. Using intravital microscopy, a decreased perfused vessel volume was observed in infected tumour nodules upon systemic delivery of EnAd, encoding the oxygen-independent fluorescent reporter UnaG to a tumour xenograft grown under an abdominal window chamber. We conclude that the attenuation of the HIF pathway upon adenoviral infection may contribute to anti-vascular and immunostimulatory effects in the periphery of established infection foci in vivo.<\/jats:p>","DOI":"10.3390\/cancers12040851","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T11:57:14Z","timestamp":1585828634000},"page":"851","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Attenuation of the Hypoxia Inducible Factor Pathway after Oncolytic Adenovirus Infection Coincides with Decreased Vessel Perfusion"],"prefix":"10.3390","volume":"12","author":[{"given":"Iris","family":"Yousaf","sequence":"first","affiliation":[{"name":"Anticancer Viruses and Cancer Vaccines Research Group, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5973-0049","authenticated-orcid":false,"given":"Jakob","family":"Kaeppler","sequence":"additional","affiliation":[{"name":"Mechanisms of Metastasis Research Group, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0218-9949","authenticated-orcid":false,"given":"Sally","family":"Frost","sequence":"additional","affiliation":[{"name":"Anticancer Viruses and Cancer Vaccines Research Group, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3825-0841","authenticated-orcid":false,"given":"Len W.","family":"Seymour","sequence":"additional","affiliation":[{"name":"Anticancer Viruses and Cancer Vaccines Research Group, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4436-360X","authenticated-orcid":false,"given":"Egon J.","family":"Jacobus","sequence":"additional","affiliation":[{"name":"Anticancer Viruses and Cancer Vaccines Research Group, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,4,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1089\/hum.2017.112","article-title":"Making Oncolytic Virotherapy a Clinical Reality: The European Contribution","volume":"28","author":"Duffy","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.omtm.2019.11.001","article-title":"Immunology of Adenoviral Vectors in Cancer Therapy","volume":"15","author":"Shaw","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2005.06.038","article-title":"Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study","volume":"77","author":"Nordsmark","year":"2005","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0167-8140(88)90225-3","article-title":"Effect of cancer chemotherapy on the hypoxic fraction of a solid tumor measured using a local tumor control assay","volume":"13","author":"Grau","year":"1998","journal-title":"Radiother. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"8960","DOI":"10.1128\/JVI.78.17.8960-8970.2004","article-title":"Replication and cytopathic effect of oncolytic vesicular stomatitis virus in hypoxic tumor cells in vitro and in vivo","volume":"78","author":"Connor","year":"2004","journal-title":"J. Virol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/mt.2008.232","article-title":"Hypoxia enhances the replication of oncolytic herpes simplex virus","volume":"17","author":"Aghi","year":"2009","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"29083","DOI":"10.1074\/jbc.270.49.29083","article-title":"Hypoxia and Mitochondrial Inhibitors Regulate Expression of Glucose Transporter-1 via Distinct Cis-acting Sequences","volume":"270","author":"Firth","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Tudisco, L., Orlandi, A., Tarallo, V., and De Falco, S. (2017). Hypoxia activates placental growth factor expression in lymphatic endothelial cells. Oncotarget, 8.","DOI":"10.18632\/oncotarget.15861"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"23757","DOI":"10.1016\/S0021-9258(17)31580-6","article-title":"Transcriptional Regulation of Genes Encoding Glycolytic Enzymes by Hypoxia-inducible Factor","volume":"269","author":"Semenza","year":"1944","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","article-title":"Hypoxia-inducible factors: Mediators of cancer progression and targets for cancer therapy","volume":"33","author":"Semenza","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular 02 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Mol. cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"9630","DOI":"10.1073\/pnas.181341498","article-title":"HIF-1\u03b1 binding to VHL is regulated by stimulus-sensitive proline hydroxylation","volume":"98","author":"Yu","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIF\u03b1 Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. The tumoursuppressor proteinVHLtargets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Masson, N., Willam, C., Maxwell, P.H., Pugh, C.W., and Ratcliffe, P.J. (2001). Independent function of two destruction domains in hypoxia-inducible factor-\u03b1 chains activated by prolyl hydroxylation. EMBO, 20.","DOI":"10.1093\/emboj\/20.18.5197"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.virol.2014.02.027","article-title":"Hypoxia-inducible factor 1 and its role in viral carcinogenesis","volume":"456\u2013457","author":"Cuninghame","year":"2014","journal-title":"Virology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1099\/jgv.0.000623","article-title":"Newcastle disease virus degrades HIF-1alpha through proteasomal pathways independent of VHL and p53","volume":"97","author":"Stanbridge","year":"2016","journal-title":"J. Gen. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/cgt.2009.84","article-title":"Down-regulation of HIF-1alpha by oncolytic reovirus infection independently of VHL and p53","volume":"17","author":"Cho","year":"2010","journal-title":"Cancer Gene Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.3892\/ijo.2015.2922","article-title":"Oncotropic H-1 parvovirus infection degrades HIF-1alpha protein in human pancreatic cancer cells independently of VHL and RACK1","volume":"46","author":"Cho","year":"2015","journal-title":"Int. J. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Mazzon, M., Peters, N.E., Loenarz, C., Krysztofinsk, E.M., Ember, S.W.J., Fergusona, B.J., Geoffrey, L., and Smith, G.L. (2013). A mechanism for induction of hypoxic response by vaccinia virus. PNAS.","DOI":"10.1073\/pnas.1302140110"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kuhn, I., Harden, P., Bauzon, M., Chartier, C., Nye, J., Thorne, S., Reid, T., Ni, S., Lieber, A., and Fisher, K. (2008). Directed evolution generates a novel oncolytic virus for the treatment of colon cancer. PLoS ONE., 3.","DOI":"10.1371\/journal.pone.0002409"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1186\/s40425-017-0277-7","article-title":"Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection","volume":"5","author":"Salazar","year":"2017","journal-title":"J. Immunother. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1186\/s40425-019-0510-7","article-title":"A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)","volume":"7","author":"Machiels","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2307\/3580034","article-title":"Comparisons among Pimonidazole Binding, Oxygen Electrode Measurements, and Radiation Response in C3H Mouse Tumors","volume":"151","author":"Raleigh","year":"1999","journal-title":"Radiat. Res."},{"key":"ref_26","first-page":"857","article-title":"VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2","volume":"130","author":"Ziogas","year":"2012","journal-title":"J. Exp. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1124\/mol.64.5.1029","article-title":"Inhibition of Vascular Endothelial Growth Factor-Induced Angiogenesis by Resveratrol through Interruption of Src-Dependent Vascular Endothelial Cadherin Tyrosine Phosphorylation","volume":"64","author":"Lin","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1093\/humrep\/deu255","article-title":"Inhibition of dual specificity phosphatase-2 by hypoxia promotes interleukin-8-mediated angiogenesis in endometriosis","volume":"29","author":"Hsiao","year":"2014","journal-title":"Hum. Reprod."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.15252\/embj.201592775","article-title":"A novel family of fluorescent hypoxia sensors reveal strong heterogeneity in tumor hypoxia at the cellular level","volume":"35","author":"Erapaneedi","year":"2016","journal-title":"EMBO J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.cell.2013.05.038","article-title":"A bilirubin-inducible fluorescent protein from eel muscle","volume":"153","author":"Kumagai","year":"2013","journal-title":"Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"561","DOI":"10.18632\/oncotarget.1767","article-title":"HIF-1\u03b1 downregulation and apoptosis in hypoxic prostate tumor cells infected with oncolytic Mammalian Orthoreovirus","volume":"5","author":"Miller","year":"2014","journal-title":"Oncotarget"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Armando, F., Gambini, M., Corradi, A., Giudice, C., Pfankuche, V.M., Brogden, G., Attig, F., von Kockritz-Blickwede, M., Baumgartner, W., and Puff, C. (2020). Oxidative Stress in Canine Histiocytic Sarcoma Cells Induced by an Infection with Canine Distemper Virus Led to a Dysregulation of HIF-1alpha Downstream Pathway Resulting in a Reduced Expression of VEGF-B in vitro. Viruses, 12.","DOI":"10.3390\/v12020200"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1091\/mbc.e13-07-0423","article-title":"Transcriptional repression of hypoxia-inducible factor-1 (HIF-1) by the protein arginine methyltransferase PRMT1","volume":"25","author":"Lafleur","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/jcp.22798","article-title":"Functional regulation of HIF-1alpha under normoxia--is there more than post-translational regulation?","volume":"227","author":"Kuschel","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"48403","DOI":"10.1074\/jbc.M209114200","article-title":"Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms","volume":"277","author":"Page","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.virol.2007.02.013","article-title":"How adenovirus strives to control cellular gene expression","volume":"363","author":"Zhao","year":"2007","journal-title":"Virology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"7707","DOI":"10.1128\/JVI.78.14.7707-7716.2004","article-title":"Structural basis for competitive inhibition of eIF4G-Mnk1 interaction by the adenovirus 100-kilodalton protein","volume":"78","author":"Cuesta","year":"2004","journal-title":"J. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1124\/mol.106.025817","article-title":"Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: A mechanism of tumor growth inhibition","volume":"70","author":"Choi","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1006\/bbrc.1999.0995","article-title":"HIF1A gene transcription is dependent on a core promoter sequence encompassing activating and inhibiting sequences located upstream from the transcription initiation site and cis elements located within the 5\u2019UTR","volume":"261","author":"Minet","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"9600","DOI":"10.1128\/jvi.71.12.9600-9607.1997","article-title":"Activation of the Adenovirus Major Late Promoter by Transcription Factors MAZ and Sp1","volume":"71","author":"Parks","year":"1997","journal-title":"J. Virol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e9966","DOI":"10.1073\/pnas.162082999","article-title":"Role of the E1A Rb-binding domain in repression of the NF-\u03baB-dependent defense against tumor necrosis factor-\u03b1","volume":"99","author":"Cook","year":"2002","journal-title":"PNAS"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1042\/BJ20080476","article-title":"Regulation of hypoxia-inducible factor-1alpha by NF-kappaB","volume":"412","author":"Kenneth","year":"2008","journal-title":"Biochem. J."},{"key":"ref_43","first-page":"6877","article-title":"Specific Oncolytic Effect of a New Hypoxia-Inducible Factor-Dependent Replicative Adenovirus on von Hippel-Lindau-Defective Renal Cell Carcinomas","volume":"63","author":"Cuevas","year":"2003","journal-title":"Cancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Pipiya, T., Southoff, H., Huang, Y., Chang, B., Heitner, B., Chen, S., Rom, W., and Hay, G.F. (2005). Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression. Gene Ther.","DOI":"10.1038\/sj.gt.3302459"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/sj.gt.3302448","article-title":"Effect of hypoxia on Ad5 infection, transgene expression and replication","volume":"12","author":"Shen","year":"2005","journal-title":"Gene Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/sj.gt.3302736","article-title":"The effect of hypoxia on the uptake, replication and lytic potential of group B adenovirus type 3 (Ad3) and type 11p (Ad11p)","volume":"13","author":"Shen","year":"2006","journal-title":"Gene Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"10712","DOI":"10.1128\/JVI.01014-06","article-title":"Loss of VHL confers hypoxia-inducible factor (HIF)-dependent resistance to vesicular stomatitis virus: Role of HIF in antiviral response","volume":"80","author":"Hwang","year":"2006","journal-title":"J. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Biel, N.M., Lee, J.A., Sorg, B.S., and Siemann, D.W. (2014). Limitations of the dorsal skinfold window chamber model in evaluating anti-angiogenic therapy during early phase of angiogenesis. Vasc. Cell, 6.","DOI":"10.1186\/2045-824X-6-17"},{"key":"ref_49","first-page":"4784","article-title":"Limitations of the Reporter Green Fluorescent Protein under Simulated Tumor Conditions","volume":"61","author":"Coralli","year":"2001","journal-title":"Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.omto.2018.06.001","article-title":"Visualizing Oncolytic Virus-Host Interactions in Live Mice Using Intravital Microscopy","volume":"10","author":"Naumenko","year":"2018","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/104303403321467199","article-title":"Intratumoral Spread of Wild-Type Adenovirus Is Limited After Local Injection of Human Xenograft Tumors: Virus Persists and Spreads Systemically at Late Time Points","volume":"14","author":"Sauthoff","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/cphc.200800296","article-title":"Oxygen microscopy by two-photon-excited phosphorescence","volume":"9","author":"Finikova","year":"2008","journal-title":"ChemPhysChem"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ccell.2015.06.009","article-title":"VEGF-Mediated Induction of PRD1-BF1\/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection","volume":"28","author":"Arulanandam","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/mt.2011.26","article-title":"Targeting tumor vasculature with an oncolytic virus","volume":"19","author":"Breitbach","year":"2011","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1186\/s40425-018-0350-x","article-title":"Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells","volume":"6","author":"Lei","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.omto.2017.03.003","article-title":"Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus","volume":"5","author":"Illingworth","year":"2017","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","article-title":"Enhancing cancer immunotherapy using antiangiogenics: Opportunities and challenges","volume":"15","author":"Fukumura","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Marino, N., Illingworth, S., Kodialbail, P., Patel, A., Calderon, H., Lear, R., Fisher, K.D., Champion, B.R., and Brown, A.C.N. (2017). Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes. PLoS ONE., 12.","DOI":"10.1371\/journal.pone.0177810"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Cawood, R., Chen, H.H., Carroll, F., Bazan-Peregrino, M., van Rooijen, N., and Seymour, L.W. (2009). Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000440"},{"key":"ref_60","first-page":"223","article-title":"Preparation and titration of CsCl-banded adenovirus stocks","volume":"Volume 1","author":"Wold","year":"2007","journal-title":"Adenovirus Methods and Protocols"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: An open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1186\/s40425-019-0807-6","article-title":"Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples","volume":"7","author":"Scott","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT\u2013PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nprot.2013.026","article-title":"Surgical implantation of an abdominal imaging window for intravital microscopy","volume":"8","author":"Ritsma","year":"2013","journal-title":"Nat. Protoc."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/4\/851\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:14:14Z","timestamp":1760174054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/4\/851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":64,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4]]}},"alternative-id":["cancers12040851"],"URL":"https:\/\/doi.org\/10.3390\/cancers12040851","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,1]]}}}